Patents by Inventor Yimin He

Yimin He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250000935
    Abstract: The present invention provides a high-stability daptomycin composition for injection and preparation method therefor and use thereof. The daptomycin composition for injection comprises daptomycin and a pharmaceutically acceptable carrier, and the pharmaceutically acceptable carrier contains a divalent metal salt, a pH regulator, and an osmotic pressure regulator; and the molar ratio of daptomycin to divalent metal salt in the daptomycin composition for injection is 1:1.0 to 1:3.5. The daptomycin composition for injection of the present invention significantly improves the stability of the preparation, facilitates the storage and transportation of the preparation at room temperature, and ensures the safety of drug use; And the preparation method of the present invention has advantages such as green environmental protection, suitability for industrialization.
    Type: Application
    Filed: May 27, 2021
    Publication date: January 2, 2025
    Inventors: Xiying YUAN, Weibao WANG, Guofeng WU, Lili YE, Jiali WU, Jingjing CAI, Yibin PAN, Juan CHA, Zhongming GAO, Qiming SUN, Yimin HE, Zuoliang WANG, Jianhong PING
  • Patent number: 11760928
    Abstract: A method of preparing an enhanced yellow-emitting carbon dots includes dissolving citric acid and urea in N,N-dimethylformamide, reacting at a temperature of 150-180° C. for 4-8 h to obtain a carbonized mixture, separating and purifying the carbonized mixture through column chromatography using an eluent prepared according to a volume ratio of dichloromethane to methanol from high to low, collecting a solution obtained by elution when the volume ratio of dichloromethane to methanol is 1:1-2, performing rotary evaporation to remove the solvent, and drying to obtain the yellow-emitting carbon dot. The yellow-emitting carbon dot with fluorescence intensity enhanced with the increase of temperature is synthesized. The yellow-emitting carbon dots has application value in the fields of temperature detection, biological imaging, photoelectric equipment and the like.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: September 19, 2023
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Chan Wang, Yimin He, Qijun Song, Jianfeng Huang, Yalan Xu, Tao Jiang, Tao Wu
  • Publication number: 20230075990
    Abstract: A method of preparing an enhanced yellow-emitting carbon dots includes dissolving citric acid and urea in N,N-dimethylformamide, reacting at a temperature of 150-180° C. for 4-8 h to obtain a carbonized mixture, separating and purifying the carbonized mixture through column chromatography using an eluent prepared according to a volume ratio of dichloromethane to methanol from high to low, collecting a solution obtained by elution when the volume ratio of dichloromethane to methanol is 1:1-2, performing rotary evaporation to remove the solvent, and drying to obtain the yellow-emitting carbon dot. The yellow-emitting carbon dot with fluorescence intensity enhanced with the increase of temperature is synthesized. The yellow-emitting carbon dots has application value in the fields of temperature detection, biological imaging, photoelectric equipment and the like.
    Type: Application
    Filed: November 10, 2022
    Publication date: March 9, 2023
    Inventors: Chan WANG, Yimin HE, Qijun SONG, Jianfeng HUANG, Yalan XU, Tao JIANG, Tao WU
  • Publication number: 20190062797
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Application
    Filed: August 20, 2018
    Publication date: February 28, 2019
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He
  • Patent number: 10053720
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 21, 2018
    Assignee: AbbView Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He
  • Publication number: 20160265018
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: TAYMAR E. HARTMAN, J. YUN TSO, YIMIN HE
  • Patent number: 9260449
    Abstract: The invention discloses a D-biotin preparation method. In the prior art, with a synthesis method utilizing malonic acid diester as raw materials, impurities are also produced along with the obtained D-biotin. The D-biotin preparation method is characterized in that with the presence of dimethyl sulfoxide and inorganic base as catalysts, methane tricarboxylic acid trialkyl ester and (3aR, 8aS, 8bS)-1,3-dibenzyl-2-oxo-10H-iminazole [3,4-d] thiophene [1,2-a] sulfuryl halide are subjected to condensation reaction in methylbenzene solvent to obtain intermediate (3 aS,4S,6aR)-1,3-dibenzyl-4-(?,?,?-3-methoxycarbonylbutyl)-4H-1H-thiophene[3,4-d]iminazol e-2,4(1H)-ketone, and the D-biotin is obtained after the intermediate is treated by the aftertreatment method. By the D-biotin preparation method, production of the impurities is avoided, quality of the biotin is greatly improved on the existing basis, and side reaction is avoided too.
    Type: Grant
    Filed: September 10, 2014
    Date of Patent: February 16, 2016
    Assignee: ZHEJIANG MEDICINE CO., LTD., XINCHANG PHARMACEUTICAL FACTORY
    Inventors: Yajin Pan, Shiqing Pi, Wenzhen Ding, Lixin Gu, Angfeng Wei, Yimin He
  • Publication number: 20150011777
    Abstract: Abstract The invention discloses a D-biotin preparation method. In the prior art, with a synthesis method utilizing malonic acid diester as raw materials, impurities are also produced along with the obtained D-biotin. The D-biotin preparation method is characterized in that with the presence of dimethyl sulfoxide and inorganic base as catalysts, methane tricarboxylic acid trialkyl ester and (3aR, 8aS, 8bS)-1,3-dibenzyl-2-oxo-10H-iminazole [3,4-d] thiophene [1,2-a] sulfuryl halide are subjected to condensation reaction in methylbenzene solvent to obtain intermediate (3 aS,4S,6aR)- 1,3 -dibenzyl-4-(?,?,?-3-methoxycarbonylbutyl)-4H- 1H-thiophene[3,4-d]iminazol e-2,4(1H)-ketone, and the D-biotin is obtained after the intermediate is treated by the aftertreatment method. By the D-biotin preparation method, production of the impurities is avoided, quality of the biotin is greatly improved on the existing basis, and side reaction is avoided too.
    Type: Application
    Filed: September 10, 2014
    Publication date: January 8, 2015
    Inventors: YAJIN PAN, SHIQING PI, WENZHEN DING, LIXIN GU, ANGFENG WEI, YIMIN HE
  • Publication number: 20140295497
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Application
    Filed: November 30, 2011
    Publication date: October 2, 2014
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He
  • Publication number: 20120065406
    Abstract: The invention discloses the improved preparation method for D-Biotin. If the composite method takes the malonic acid diester as the raw material, the finial biotin will be generated with impurities. The features of the invention refers to the improved preparation method for D-Biotin includes: firstly, (3aS,4S,6aR)-1,3-dibenzyl-4-(?,?,?-3 -alkoxycarbonyl bytyl)-4H-1H-thiophene[3,4-d]iminazole-2,4(1H)-ketone is got after the methane tricarboxylic acid trialkyl ester and (3aR,8aS,8bS)-1,3-dibenzyl-2-oxo-10H-iminazole[3,4-d]thiophene[1,2-a]sulfuryl halide have the condensation reaction in the alkaline environment and then D-Biotin can be got after the reaction process of hydrolysis, decarboxylation and closed loop. The invention succeeds in greatly improving the biotin quality from the original basis and simultaneously avoids the generation of impurities and the occurrence of side reaction.
    Type: Application
    Filed: May 20, 2010
    Publication date: March 15, 2012
    Applicant: Zhejiang Medicine Co., Ltd., Xinchang Pharmaceutical Factory
    Inventors: Yajin Pan, Shiqing Pi, Wenzhen Ding, Lixin Gu, Angfeng Wei, Yimin He
  • Publication number: 20070125959
    Abstract: An open-channel radiation sterilization system, comprising a channel, a radiation source and an electrical control means, characterized in that the fluid to be sterilized flows in under the radiation source and the sterilized fluid flows out above the radiation source in the channel; a first partition wall and a second partition wall are both provided in the channel, partitioning the channel into three parts, i.e.
    Type: Application
    Filed: November 27, 2006
    Publication date: June 7, 2007
    Inventors: Jian Chen, Yimin He